Matthew Pollman

A cardiologist and molecular biologist by training, Dr. Pollman most recently served as Executive Vice President for NaviGate Cardiac Structures, Inc. Prior to this appointment, he served as the Chief Medical Officer for Juventas Therapeutics and was the Founding CEO, President and Chief Scientific Officer of CV Ingenuity, a clinical stage company acquired by Covidien. Prior to founding CV Ingenuity, he served as Medical Director, Research and Development, at Abbott Vascular and was the principal medical and scientific strategist and advisor for the R&D pipeline and Business Development portfolios.